INCREASED THROMBOEMBOLIC RISK OF JAK INHIBITORS AFTER SWITCHING FROM BIOLOGIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Eun, Y. [1 ]
Seo, G. H. [2 ]
Kang, S. Y. [3 ]
Lee, S. [3 ]
Kim, H. [3 ,4 ]
Cha, H. S. [3 ]
Koh, E. M. [3 ]
Lee, J. [3 ]
机构：
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Med, Sch Med, Seoul, South Korea
[2] Hlth Insurance Review & Assessment Serv, Wonju, South Korea
[3] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Dept Med Humanities, Samsung Med Ctr, Sch Med, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.4952
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0418
引用
收藏
页码：1337 / 1337
页数：1
相关论文
共 50 条
  • [31] The Risk of Tuberculosis (TB) in Rheumatoid Arthritis Patients Treated with TNF Inhibitors and the Safety of Resuming Biologic Dmards for Patients Who Developed TB after Anti-TNF Treatment
    Cho, Soo-Kyung
    Kim, Dam
    Jeong, Hye-Jin
    Sohn, Il Woong
    Won, Soyoung
    Han, Minkyung
    Lee, Jiyoung
    Jang, Eun Jin
    Bae, Sang-Cheol
    Sung, Yoon-Kyoung
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [32] Biologic Switching Rates Among Patients With Rheumatoid Arthritis
    Rosenblatt, L.
    Lobo, F.
    Cockrum, P.
    Wang, L.
    Alemao, E.
    Baser, O.
    Yuce, H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S998 - S998
  • [33] BIOLOGIC SWITCHING RATES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Rosenblatt, L.
    Lobo, F.
    Cockrum, P.
    Wang, L.
    Alemao, E.
    Baser, O.
    Yuce, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 561 - 561
  • [34] Switching Biologic Therapy in a Population of Rheumatoid Arthritis Patients
    Souza, Branca
    Valim, Juliana
    Chaer, Fernanda
    Guimaraes, Fernanda
    Lima, Veronica
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [35] Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings
    Philippoteaux, Cecile
    Deprez, Valentine
    Nottez, Aurore
    Cailliau, Emeline
    Houvenagel, Eric
    Deprez, Xavier
    Philippe, Peggy
    Pascart, Tristan
    Flipo, Rene-Marc
    Goeb, Vincent
    Letarouilly, Jean-Guillaume
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [36] Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Initiating Biologic and Non-biologic DMARDs, a Population-based Study
    Li, Lingyi
    Lu, Na
    Lacaille, Diane
    Xie, Hui
    Esdaile, John
    Avina-Zubieta, J. Antonio
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [37] Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs
    Michel, Murielle
    Vincent, Fabien B.
    Rio, Simon
    Leon, Nathalie
    Marcelli, Christian
    JOINT BONE SPINE, 2016, 83 (02) : 237 - 238
  • [38] Rheumatoid Arthritis and the Risk for Interstitial Lung Disease: A Comparison of Risk Associated with Biologic and Conventional Dmards
    Xie, Fenglong
    Annapureddy, Narender
    Chen, Lang
    Lobo, Jason Leonard
    Oates, Jim C.
    Shah, Ankoor
    Yun, Huifeng
    Yang, Shuo
    Curtis, Jeffrey R.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [39] Comparable Malignancy Risk of Janus Kinase Inhibitors with Conventional Synthetic and Biologic DMARDs in Asian Patients with Rheumatoid Arthritis: A Comprehensive Analysis from Two Medical Centers
    Chen, Ming-Han
    Chen, Mao-Yuan
    Chang, Shih-Hsin
    Chen, Der-Yuan
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1055 - 1057
  • [40] BIOLOGIC DMARDS TREATMENT RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO THE MOSCOW ARTHRITIS REGISTRY (MERA)
    Koltsova, E.
    Zhilyaev, E.
    Lukina, G.
    Shmidt, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1379 - 1379
12345